V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033037 | 210009733 | 1.76 | 74.7 | Curative (C) | 2017-02-08 | 2017-03-18 | Temozolomide + RT | N | Y | 210019691 | TEMOZOLOMIDE + RT |
| 210033039 | 210009778 | null | 85.9 | Curative (C) | 2013-02-16 | 2014-01-27 | Trial Unspecified | Y | N | 210019845 | TRIAL |
| 210033040 | 210009783 | 0 | 75 | Curative (C) | 2016-02-12 | 2016-02-21 | Temozolomide + RT | N | Y | 210019855 | TEMOZOLOMIDE + RT |
| 210033041 | 210020231 | 1.8 | 62 | Curative (C) | 2015-09-03 | 2015-09-17 | Temozolomide + RT | 02 | null | 210019894 | TEMOZOLOMIDE + RT |
| 210033042 | 210009800 | 1.7 | null | Curative (C) | 2016-07-21 | 2016-07-23 | Trial Unspecified | 1 | N | 210019904 | TRIAL |
| 210033043 | 210009802 | 1.7 | 76 | null | 2016-06-26 | 2016-07-18 | Temozolomide + RT | null | null | 210019905 | TEMOZOLOMIDE + RT |
| 210033045 | 210009824 | 1.73 | 17.8 | Palliative (P) | 2018-02-06 | 2018-03-02 | Temozolomide + RT | N | null | 210019979 | TEMOZOLOMIDE + RT |
| 210033046 | 210026983 | null | 63 | Curative (C) | 2018-10-31 | 2018-11-19 | Temozolomide + RT | N | null | 210020022 | TEMOZOLOMIDE + RT |
| 210033047 | 210009864 | 1.61 | 107 | Disease modification (D) | 2015-10-02 | 2015-10-08 | Trial Unspecified | 01 | Y | 210020105 | TRIAL |
| 210033048 | 210009889 | 1.86 | 90 | Adjuvant (A) | 2014-11-25 | 2014-11-25 | Temozolomide + RT | N | N | 210020202 | TEMOZOLOMIDE + RT |
| 210033049 | 210009896 | 1.77 | 47 | null | null | 2015-05-31 | Trial Unspecified | 1 | Y | 210020262 | TRIAL |
| 210033050 | 210009898 | 1.6 | 65.4 | Curative (C) | 2015-10-12 | 2015-11-02 | Temozolomide + RT | N | N | 210020274 | TEMOZOLOMIDE + RT |
| 210033051 | 210009902 | 1.66 | 72.9 | Curative (C) | 2016-08-25 | 2016-09-09 | Trial Unspecified | 01 | Y | 210020279 | TRIAL |
| 210033052 | 210020315 | null | 90 | Curative (C) | 2014-06-07 | 2014-06-09 | CHOP-OR TRIAL | 2 | null | 210020286 | TRIAL |
| 210033053 | 210009910 | 1.63 | null | Curative (C) | 2015-06-23 | 2015-07-07 | Temozolomide + RT | N | N | 210020306 | TEMOZOLOMIDE + RT |
| 210033054 | 210009917 | 1.73 | 91.9 | Curative (C) | null | 2017-12-29 | CNS Medbl HR Cyclo+Vinc | 2 | Y | 210020337 | TRIAL |
| 210033055 | 210009920 | 1.81 | 109.6 | Curative (C) | null | 2014-02-10 | Temozolomide + RT | null | null | 210020338 | TEMOZOLOMIDE + RT |
| 210033056 | 210009923 | 1.82 | 31.1 | Curative (C) | 2015-11-03 | 2015-11-10 | Trial Unspecified | Y | N | 210020354 | TRIAL |
| 210033057 | 210020334 | null | null | Adjuvant (A) | 2014-02-23 | 2014-04-24 | ESPHALL TRIAL | N | null | 210020375 | TRIAL |
| 210033058 | 210020334 | 1.81 | 66.6 | Curative (C) | null | 2016-10-24 | Trial Unspecified | 01 | Y | 210020375 | TRIAL |
| 210033059 | 210009932 | 0 | 70.35 | Curative (C) | 2019-05-01 | 2019-05-09 | Trial Unspecified | Y | Y | 210020401 | TRIAL |
| 210033060 | 210009967 | 1.73 | 73 | Adjuvant (A) | 2015-10-04 | 2015-10-04 | Temozolomide + RT | 02 | N | 210020530 | TEMOZOLOMIDE + RT |
| 210033061 | 210009989 | 1.19 | 97 | Palliative (P) | 2013-11-26 | 2014-01-27 | Temozolomide + RT | 02 | N | 210020606 | TEMOZOLOMIDE + RT |
| 210033062 | 210010014 | 0 | 96.3 | Adjuvant (A) | 2016-09-20 | 2016-11-25 | Temozolomide + RT | N | Y | 210020678 | TEMOZOLOMIDE + RT |
| 210033063 | 210010018 | 1.72 | 0 | Adjuvant (A) | 2018-03-12 | 2018-03-12 | Trial Unspecified | 01 | null | 210020704 | TRIAL |
| 210033064 | 210010023 | 0 | 97 | Curative (C) | 2014-09-30 | 2014-10-14 | Temozolomide + RT | N | Y | 210020737 | TEMOZOLOMIDE + RT |
| 210033066 | 210010036 | 1.63 | 58.9 | Curative (C) | 2018-10-25 | 2018-11-25 | Temozolomide + RT | N | null | 210020797 | TEMOZOLOMIDE + RT |
| 210033067 | 210010039 | null | 79.4 | Curative (C) | 2019-02-23 | 2019-04-20 | CNS Medbl HR Cyclo+Vinc | 01 | Y | 210020804 | TRIAL |
| 210033068 | 210010065 | 1.75 | 85.9 | Curative (C) | 2014-06-20 | 2014-06-21 | Trial Unspecified | N | Y | 210020896 | TRIAL |
| 210033069 | 210010077 | 1.6 | 77.3 | Palliative (P) | 2015-04-14 | 2015-05-23 | Temozolomide + RT | 02 | Y | 210020932 | TEMOZOLOMIDE + RT |
| 210033070 | 210010081 | 1.66 | 99.3 | Curative (C) | null | 2016-10-12 | Temozolomide + RT | N | N | 210020935 | TEMOZOLOMIDE + RT |
| 210033071 | 210010084 | null | 69.1 | Curative (C) | 2013-09-21 | 2013-11-12 | Temozolomide + RT | N | N | 210020946 | TEMOZOLOMIDE + RT |
| 210033072 | 210037413 | 1.71 | 15.4 | Curative (C) | null | 2014-07-22 | Trial Unspecified | Y | N | 210020956 | TRIAL |
| 210033073 | 210010088 | null | 78.5 | null | 2016-11-25 | 2016-11-30 | ESPHALL TRIAL | null | null | 210020961 | TRIAL |
| 210033074 | 210010096 | 1.8 | null | Palliative (P) | 2013-08-01 | 2013-08-16 | Temozolomide + RT | N | N | 210020995 | TEMOZOLOMIDE + RT |
| 210033075 | 210010101 | null | 101.6 | null | 2015-08-08 | 2015-08-29 | Temozolomide + RT | N | null | 210021004 | TEMOZOLOMIDE + RT |
| 210033076 | 210030922 | null | 16.2 | Palliative (P) | 2017-09-11 | 2017-11-12 | Trial Unspecified | 01 | null | 210021061 | TRIAL |
| 210033077 | 210010118 | 1.49 | 90 | Curative (C) | 2015-12-05 | 2015-12-19 | Temozolomide + RT | N | N | 210021074 | TEMOZOLOMIDE + RT |
| 210033079 | 210020492 | null | 53.6 | Disease modification (D) | 2016-04-01 | 2016-06-03 | CNS HGG HERBY Bevacizumab | null | null | 210021081 | TRIAL |
| 210033080 | 210010129 | null | null | Palliative (P) | null | 2016-06-26 | Temozolomide + RT | N | N | 210021134 | TEMOZOLOMIDE + RT |
| 210033081 | 210010137 | null | 64.5 | Curative (C) | null | 2019-04-24 | Temozolomide + RT | 02 | N | 210021164 | TEMOZOLOMIDE + RT |
| 210033082 | 210010141 | null | 78.9 | Neo-adjuvant (N) | 2014-11-23 | 2015-04-05 | Trial Unspecified | N | N | 210021183 | TRIAL |
| 210033083 | 210010144 | 1.28 | 0 | Curative (C) | 2016-02-10 | 2016-02-10 | Trial Unspecified | Y | null | 210021185 | TRIAL |
| 210033086 | 210020522 | null | 59.5 | Disease modification (D) | 2016-05-19 | 2016-05-21 | Trial Unspecified | Y | N | 210021232 | TRIAL |
| 210033087 | 210020525 | 1.51 | 53.6 | Disease modification (D) | 2014-06-17 | 2014-06-18 | Trial Unspecified | Y | Y | 210021237 | TRIAL |
| 210033088 | 210020531 | 1.72 | 74.3 | Curative (C) | 2018-05-22 | 2018-10-03 | Trial Unspecified | 1 | Y | 210021253 | TRIAL |
| 210033089 | 210010177 | null | 48 | Curative (C) | null | 2019-11-14 | Temozolomide + RT | null | null | 210021285 | TEMOZOLOMIDE + RT |
| 210033090 | 210020544 | 1.7 | 68.7 | Palliative (P) | 2015-08-18 | 2015-08-23 | Trial Unspecified | 1 | null | 210021292 | TRIAL |
| 210033091 | 210010191 | 1.79 | 76.2 | Unknown (U) | 2018-08-11 | 2018-08-27 | Temozolomide + RT | 02 | N | 210021334 | TEMOZOLOMIDE + RT |
| 210033092 | 210010192 | 1.76 | 128.3 | Disease modification (D) | 2014-12-31 | 2015-03-09 | Temozolomide + RT | null | null | 210021338 | TEMOZOLOMIDE + RT |